North Dakota § 54-52.1-16 Uniform group insurance program - Collaborative drug therapy program - Continuing appropriation

North Dakota Statutes

§ 54-52.1-16 — Uniform group insurance program - Collaborative drug therapy program - Continuing appropriation

North Dakota § 54-52.1-16

Title 54State Government

Ch. 54-52.1Uniform Group Insurance Program

This text of North Dakota § 54-52.1-16 (Uniform group insurance program - Collaborative drug therapy program - Continuing appropriation) is published on Counsel Stack Legal Research, covering North Dakota primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

N.D. Cent. Code § 54-52.1-16 (2026).

Text

Continuing appropriation.

1.The board may establish a collaborative drug therapy program available to individuals in the medical and hospital benefits coverage group. The purpose of the collaborative drug therapy program is to improve the health of individuals in identified health populations and to manage health care expenditures.

2.Under the program, the board may involve physicians, pharmacists, and other health professionals to coordinate health care for individuals in identified health populations in order to improve health outcomes and reduce spending on care for the identified health problem. Under the program, pharmacists and other health professionals may be reimbursed for providing face-to-face collaborative drug therapy services to covered individuals in the identified health

Free access — add to your briefcase to read the full text and ask questions with AI

Continuing appropriation.
1. The board may establish a collaborative drug therapy program available to individuals
in the medical and hospital benefits coverage group. The purpose of the collaborative
drug therapy program is to improve the health of individuals in identified health
populations and to manage health care expenditures.
2. Under the program, the board may involve physicians, pharmacists, and other health
professionals to coordinate health care for individuals in identified health populations in
order to improve health outcomes and reduce spending on care for the identified
health problem. Under the program, pharmacists and other health professionals may
be reimbursed for providing face-to-face collaborative drug therapy services to
covered individuals in the identified health population. To encourage enrollment in the
plan, the board may provide incentives to covered individuals in the identified health
population which may include waived or reduced copayment for related treatment
drugs and supplies.
3. The board may request the assistance of the North Dakota pharmacists association or
a specified delegate to implement a formalized disease management program with the
approval of the prescriptive practices committee established in section 43-15-31.4,
which must serve to standardize chronic disease care and improve patient outcomes.
This program must facilitate enrollment procedures, provide standards of care, enable
consistent documentation of clinical and economic outcomes, and structure an
outcomes reporting system.
4. The board may seek and accept private contributions, gifts, and grants-in-aid from the
federal government, private industry, and other sources for a collaborative drug
therapy program for identified health populations. Any funds that may become
available through contributions, gifts, grants-in-aid, or other sources to the board for a
collaborative drug therapy program are appropriated to the board on a continuing
basis.